Benefit conversations still tend to treat menopause, heart health, weight, diabetes, pharmacy coverage, and care navigation as separate issues. They are not separate for the woman trying to navigate them.
GLP-1 drugs like Wegovy, Zepbound, Ozempic, and Mounjaro are transforming care—but without the right guardrails, costs can spiral. Our GLP-1 Planning Checklist gives HR and Finance leaders 7 proven strategies to balance cost, access, and outcomes.
If you manage employer benefits, you’re staring at a 2026 puzzle: demand for GLP-1 medications keeps climbing while prices remain elevated, and oral options may expand utilization further.
They promise weight loss. But without a plan, GLP-1s can quietly become your biggest prescription care expense.
An expert-led webinar with a pharmacist, a nurse, a doctor, and an HR leader sharing practical steps employers should take to balance cost, access, and outcomes